Alfredo García-Arieta1, John Gordon2, Henrike Potthast3. 1. Division of Pharmacology and Clinical Evaluation, Department of Human Use Medicines, Spanish Agency for Medicines and Health Care Products, Madrid, Spain. 2. Division of Biopharmaceutics Evaluation, Bureau of Pharmaceutical Sciences, Therapeutic Products Directorate, Health Canada, Ottawa, Canada. 3. Subdepartment of Biostatistics and Pharmacokinetics, Federal Institute for Drugs and Medical Devices, Bonn, Germany.
Authors: Tatiana R Alonso; Adrianna Gagol; Maximilian Scherer; Antonio Matji; Santiago Torrado-Santiago; Dolores R Serrano; Alfredo Garcia-Arieta; Juan J Torrado Journal: Patient Prefer Adherence Date: 2018-09-26 Impact factor: 2.711